Based on the information provided, I was unable to find a direct answer to how often vaccinations need repeating after taking Cosentyx (secukinumab). However, I can provide some context around the topic.
Cosentyx is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body (interleukin-17A) that contributes to inflammation [1].
Monoclonal antibody therapies like Cosentyx can impact the immune system's response to vaccines [2]. Therefore, it is essential to consider vaccination schedules when using such medications. According to the Centers for Disease Control and Prevention (CDC), "patients receiving immunosuppressive therapy, including tumor necrosis factor (TNF) blockers, should receive inactivated vaccines, when available" [3]. However, the specific guidelines for Cosentyx might differ, and it is crucial to consult healthcare professionals for personalized advice.
To find more detailed and up-to-date information on Cosentyx and vaccinations, you can consult resources like DrugPatentWatch.com, which provides extensive data and news on pharmaceutical patents, drug development, and related topics [4].
Sources:
1. Cosentyx (secukinumab) [Internet]. Novartis Pharmaceuticals Corporation; 2022 [cited 2023 Feb 16]. Available from: https://www.cosentyx.com/
2. Vaccines - people with weakened immune systems [Internet]. Centers for Disease Control and Prevention; 2022 [cited 2023 Feb 16]. Available from: https://www.cdc.gov/vaccines/adults/rec-vac/people-with-weakened-immune-systems.html
3. Table 3-2. Preferred vaccine schedule for adults aged 19 years and older - by vaccine and age group - United States, 2022 [Internet]. Centers for Disease Control and Prevention; 2022 [cited 2023 Feb 16]. Available from: https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-tables.html
4. DrugPatentWatch - Pharmaceutical & Biotech Patent Intelligence [Internet]. DrugPatentWatch.com; [cited 2023 Feb 16]. Available from: https://www.drugpatentwatch.com/